BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22034905)

  • 1. Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells.
    Furuta K; Arao T; Sakai K; Kimura H; Nagai T; Tamura D; Aomatsu K; Kudo K; Kaneda H; Fujita Y; Matsumoto K; Yamada Y; Yanagihara K; Sekijima M; Nishio K
    Cancer Sci; 2012 Feb; 103(2):221-7. PubMed ID: 22034905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and isoform variation analysis using Affymetrix Exon Arrays.
    Bemmo A; Benovoy D; Kwan T; Gaffney DJ; Jensen RV; Majewski J
    BMC Genomics; 2008 Nov; 9():529. PubMed ID: 18990248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
    Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
    Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
    Rossi E; Klersy C; Manca R; Zuffardi O; Solcia E
    Hum Pathol; 2011 Dec; 42(12):1937-45. PubMed ID: 21676433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
    BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Ito H; Kasami M; Sasaki N; Shima H; Ikeda M; Tao H; Goto M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Cancer Sci; 2011 Oct; 102(10):1782-8. PubMed ID: 21777349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.
    Reiter JL; Threadgill DW; Eley GD; Strunk KE; Danielsen AJ; Sinclair CS; Pearsall RS; Green PJ; Yee D; Lampland AL; Balasubramaniam S; Crossley TD; Magnuson TR; James CD; Maihle NJ
    Genomics; 2001 Jan; 71(1):1-20. PubMed ID: 11161793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
    Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S
    Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
    Kunii K; Davis L; Gorenstein J; Hatch H; Yashiro M; Di Bacco A; Elbi C; Lutterbach B
    Cancer Res; 2008 Apr; 68(7):2340-8. PubMed ID: 18381441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
    Li XW; Shi BY; Yang QL; Wu J; Wu HM; Wang YF; Wu ZJ; Fan YM; Wang YP
    BMC Cancer; 2015 Dec; 15():954. PubMed ID: 26674321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
    Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.